BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 18677282)

  • 1. Galectin-3 upregulation during tumor progression in head and neck cancer.
    Saussez S; Decaestecker C; Mahillon V; Cludts S; Capouillez A; Chevalier D; Vet HK; André S; Toubeau G; Leroy X; Gabius HJ
    Laryngoscope; 2008 Sep; 118(9):1583-90. PubMed ID: 18677282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased expression and altered intracellular distribution of adhesion/growth-regulatory lectins galectins-1 and -7 during tumour progression in hypopharyngeal and laryngeal squamous cell carcinomas.
    Saussez S; Decaestecker C; Lorfevre F; Chevalier D; Mortuaire G; Kaltner H; André S; Toubeau G; Gabius HJ; Leroy X
    Histopathology; 2008 Mar; 52(4):483-93. PubMed ID: 18315601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Galectin-8 up-regulation during hypopharyngeal and laryngeal tumor progression and comparison with galectin-1, -3 and -7.
    Cludts S; Decaestecker C; Mahillon V; Chevalier D; Kaltner H; André S; Remmelink M; Leroy X; Gabius HJ; Saussez S
    Anticancer Res; 2009 Dec; 29(12):4933-40. PubMed ID: 20044599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of matrix metalloproteinase-9 as an independent prognostic marker in laryngeal and hypopharyngeal cancer with opposite correlations to adhesion/growth-regulatory galectins-1 and -7.
    Saussez S; Cludts S; Capouillez A; Mortuaire G; Smetana K; Kaltner H; André S; Leroy X; Gabius HJ; Decaestecker C
    Int J Oncol; 2009 Feb; 34(2):433-9. PubMed ID: 19148478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The helicase-like transcription factor is a strong predictor of recurrence in hypopharyngeal but not in laryngeal squamous cell carcinomas.
    Capouillez A; Debauve G; Decaestecker C; Filleul O; Chevalier D; Mortuaire G; Coppée F; Leroy X; Belayew A; Saussez S
    Histopathology; 2009 Jul; 55(1):77-90. PubMed ID: 19614770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The effect of the microenvironment of head and neck cancers on tumor progression].
    Lukits J
    Magy Onkol; 2009 Mar; 53(1):51-9. PubMed ID: 19318327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased expression of macrophage migration inhibitory factor during progression to hypopharyngeal squamous cell carcinoma.
    Cludts S; Decaestecker C; Johnson B; Lechien J; Leroy X; Kindt N; Kaltner H; André S; Gabius HJ; Saussez S
    Anticancer Res; 2010 Sep; 30(9):3313-9. PubMed ID: 20944103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High level of galectin-1 expression is a negative prognostic predictor of recurrence in laryngeal squamous cell carcinomas.
    Saussez S; Decaestecker C; Lorfevre F; Cucu DR; Mortuaire G; Chevalier D; Wacreniez A; Kaltner H; André S; Toubeau G; Camby I; Gabius HJ; Kiss R
    Int J Oncol; 2007 May; 30(5):1109-17. PubMed ID: 17390012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Galectin 7 (p53-induced gene 1): a new prognostic predictor of recurrence and survival in stage IV hypopharyngeal cancer.
    Saussez S; Cucu DR; Decaestecker C; Chevalier D; Kaltner H; André S; Wacreniez A; Toubeau G; Camby I; Gabius HJ; Kiss R
    Ann Surg Oncol; 2006 Jul; 13(7):999-1009. PubMed ID: 16788763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of galectin-3-reactive ligands in squamous cancer and normal epithelial cells as a marker of differentiation.
    Plzák J; Smetana K; Hrdlicková E; Kodet R; Holíková Z; Liu FT; Dvoránkova B; Kaltner H; Betka J; Gabius HJ
    Int J Oncol; 2001 Jul; 19(1):59-64. PubMed ID: 11408923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Galectin-3, an endogenous lectin, as a tool for monitoring cell differentiation in head and neck carcinomas with implications for lectin-glycan functionality.
    Betka J; Plzák J; Smetana K; Gabius HJ
    Acta Otolaryngol; 2003 Jan; 123(2):261-3. PubMed ID: 12701754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of Jab1 expression in laryngeal squamous cell carcinomas.
    Dong Y; Sui L; Watanabe Y; Yamaguchi F; Hatano N; Tokuda M
    Clin Cancer Res; 2005 Jan; 11(1):259-66. PubMed ID: 15671554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Galectin-3 - an emerging prognostic indicator in advanced head and neck carcinoma.
    Plzák J; Betka J; Smetana K; Chovanec M; Kaltner H; André S; Kodet R; Gabius HJ
    Eur J Cancer; 2004 Oct; 40(15):2324-30. PubMed ID: 15454259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Galectin-1: a link between tumor hypoxia and tumor immune privilege.
    Le QT; Shi G; Cao H; Nelson DW; Wang Y; Chen EY; Zhao S; Kong C; Richardson D; O'Byrne KJ; Giaccia AJ; Koong AC
    J Clin Oncol; 2005 Dec; 23(35):8932-41. PubMed ID: 16219933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Galectin-3 expression in non-small cell lung carcinoma.
    Puglisi F; Minisini AM; Barbone F; Intersimone D; Aprile G; Puppin C; Damante G; Paron I; Tell G; Piga A; Di Loreto C
    Cancer Lett; 2004 Aug; 212(2):233-9. PubMed ID: 15279903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Skp2, p27kip1 and EGFR assessment in head and neck squamous cell carcinoma: prognostic implications.
    Carracedo DG; Astudillo A; Rodrigo JP; Suarez C; Gonzalez MV
    Oncol Rep; 2008 Sep; 20(3):589-95. PubMed ID: 18695910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low COX2 in tumor and upregulation in stroma mark laryngeal squamous cell carcinoma progression.
    Kourelis K; Vandoros G; Kourelis T; Papadas T; Goumas P; Sotiropoulou-Bonikou G
    Laryngoscope; 2009 Sep; 119(9):1723-9. PubMed ID: 19554635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The determination of the levels of circulating galectin-1 and -3 in HNSCC patients could be used to monitor tumor progression and/or responses to therapy.
    Saussez S; Lorfevre F; Lequeux T; Laurent G; Chantrain G; Vertongen F; Toubeau G; Decaestecker C; Kiss R
    Oral Oncol; 2008 Jan; 44(1):86-93. PubMed ID: 17350328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of galectin-1 at the tumor invasion front is associated with poor prognosis in early-stage oral squamous cell carcinoma.
    Chiang WF; Liu SY; Fang LY; Lin CN; Wu MH; Chen YC; Chen YL; Jin YT
    Oral Oncol; 2008 Apr; 44(4):325-34. PubMed ID: 17588803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significance of galectins-1, -3, -4 and -7 in the progression of squamous cell carcinoma of the tongue.
    Alves PM; Godoy GP; Gomes DQ; Medeiros AM; de Souza LB; da Silveira EJ; Vasconcelos MG; Queiroz LM
    Pathol Res Pract; 2011 Apr; 207(4):236-40. PubMed ID: 21397408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.